Enlitic has secured a $1.5 million contract to migrate over 71 million clinical files for Penn Medicine Doylestown Health, reinforcing its foothold in the US healthcare IT sector.
- US$1.5 million contract signed with Penn Medicine Doylestown Health
- Migration of 71 million legacy clinical files into Enlitic’s modern archive
- Project to commence in Q2 2026 and complete within the year
- Laitek, Enlitic’s subsidiary, to execute the bespoke data migration
- Opportunity to expand relationship with Penn Medicine through additional solutions
Enlitic Strengthens US Healthcare Presence
Enlitic, Inc. (ASX:ENL), an AI-driven medical imaging software company, has announced a significant contract win with Penn Medicine Doylestown Health, part of the prestigious University of Pennsylvania Health System. The US$1.5 million deal involves migrating over 71 million legacy clinical files into a modernised archive structure using Enlitic’s proprietary platform.
This project marks a continuation of Enlitic’s collaboration with Penn Medicine, highlighting the trust placed in its subsidiary Laitek’s specialised capabilities. Laitek will manage the complex data transformation, indexing, and validation processes necessary to ensure seamless clinical access to historical patient records.
A Bespoke Solution for a Leading Academic Health System
Penn Medicine is recognised globally for its academic excellence and healthcare innovation. The Doylestown Health facility, serving Bucks County and surrounding areas, benefits from this integration as it modernises its electronic medical record archives. Enlitic’s bespoke solution is designed to preserve data integrity and clinical utility, addressing a growing need among healthcare providers to upgrade legacy systems without disrupting patient care.
CEO Michael Sistenich emphasised the strategic importance of the contract, noting that healthcare providers worldwide face increasing pressure to modernise data archives. He described Laitek’s expertise as a key differentiator that positions Enlitic as a trusted partner for complex clinical data projects.
Looking Beyond the Migration
While the immediate contract value is US$1.5 million, Enlitic is optimistic about expanding its footprint within Penn Medicine. The company intends to leverage this project as a springboard for implementing additional AI-driven solutions that enhance clinical workflows and data management capabilities.
The migration project is scheduled to begin in the second quarter of 2026 and is expected to conclude by the end of the calendar year. This timeline reflects the scale and complexity of handling tens of millions of clinical files, underscoring the technical sophistication required.
For investors and industry watchers, this contract not only validates Enlitic’s technology but also signals growing demand for AI-enabled healthcare IT solutions in the US market.
Bottom Line?
Enlitic’s latest contract cements its role in modernising US healthcare data, setting the stage for broader adoption of its AI solutions.
Questions in the middle?
- What additional solutions might Enlitic deploy within Penn Medicine following this migration?
- How will Enlitic manage the technical challenges of migrating such a vast volume of clinical data?
- Could this contract lead to similar deals with other major US health systems?